SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-039205
Filing Date
2021-07-29
Accepted
2021-07-29 16:58:53
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-10q_20210630.htm   iXBRL 10-Q 1866767
2 EX-10.2 cycn-ex102_241.htm EX-10.2 1431274
3 EX-31.1 cycn-ex311_8.htm EX-31.1 9229
4 EX-31.2 cycn-ex312_9.htm EX-31.2 9257
5 EX-32.1 cycn-ex321_7.htm EX-32.1 4952
6 EX-32.2 cycn-ex322_6.htm EX-32.2 4955
  Complete submission text file 0001564590-21-039205.txt   7911701

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cycn-20210630.xsd EX-101.SCH 44355
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycn-20210630_cal.xml EX-101.CAL 38484
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycn-20210630_def.xml EX-101.DEF 144161
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20210630_lab.xml EX-101.LAB 370737
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20210630_pre.xml EX-101.PRE 264957
12 EXTRACTED XBRL INSTANCE DOCUMENT cycn-10q_20210630_htm.xml XML 1084134
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 211128321
SIC: 2834 Pharmaceutical Preparations